BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23040046)

  • 1. Immunoreactivity assessment of hepatitis C virus NS3 protease and NS5A proteins expressed in TOPO cloning system.
    Alaee M; Rajabi P; Sharifi Z; Farajollahi MM
    J Microbiol Immunol Infect; 2014 Aug; 47(4):282-91. PubMed ID: 23040046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunoreactivity studies on synthetic peptides deriving from immunodominant region of hepatitis C virus NS5a gene].
    Shi LL; Dou XG; Feng GH; Fields H; Khudyakov Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):344-7. PubMed ID: 15650785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus.
    Neville JA; Prescott LE; Bhattacherjee V; Adams N; Pike I; Rodgers B; El-Zayadi A; Hamid S; Dusheiko GM; Saeed AA; Haydon GH; Simmonds P
    J Clin Microbiol; 1997 Dec; 35(12):3062-70. PubMed ID: 9399495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the role of NS3 and NS5A non-structural genes of hepatitis C virus genotype 3a local isolates in apoptosis.
    Sabri S; Idrees M; Rafique S; Ali A; Iqbal M
    Int J Infect Dis; 2014 Aug; 25():38-44. PubMed ID: 24845365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Truncated HCV-NS3 Protein for Potential Applications in Immunization and Diagnosis.
    Javadi F; Rahimi P; Modarressi MH; Bolhassani A; Ardestani MS; Sadat SM; Aghasadeghi MR
    Clin Lab; 2016 Jul; 62(7):1271-1278. PubMed ID: 28164628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV NS3 serine protease-neutralizing single-chain antibodies isolated by a novel genetic screen.
    Gal-Tanamy M; Zemel R; Berdichevsky Y; Bachmatov L; Tur-Kaspa R; Benhar I
    J Mol Biol; 2005 Apr; 347(5):991-1003. PubMed ID: 15784258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus core, NS3, NS4B and NS5A are the major immunogenic proteins in humoral immunity in chronic HCV infection.
    Sillanpää M; Melén K; Porkka P; Fagerlund R; Nevalainen K; Lappalainen M; Julkunen I
    Virol J; 2009 Jun; 6():84. PubMed ID: 19549310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3.
    Butkiewicz N; Yao N; Zhong W; Wright-Minogue J; Ingravallo P; Zhang R; Durkin J; Standring DN; Baroudy BM; Sangar DV; Lemon SM; Lau JY; Hong Z
    J Virol; 2000 May; 74(9):4291-301. PubMed ID: 10756044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
    Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
    Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-expression and characterization of NS3 and NS5A of Hepatitis C virus genotype 3a.
    Anwar MI; Iqbal M; Yousef MS; Rahman M
    Microb Cell Fact; 2013 Nov; 12():111. PubMed ID: 24238670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential sensitivity of 5'UTR-NS5A recombinants of hepatitis C virus genotypes 1-6 to protease and NS5A inhibitors.
    Li YP; Ramirez S; Humes D; Jensen SB; Gottwein JM; Bukh J
    Gastroenterology; 2014 Mar; 146(3):812-821.e4. PubMed ID: 24262279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus.
    Lodrini S; Bagaglio S; Canducci F; De Mitri MS; Andreone P; Loggi E; Lazzarin A; Clementi M; Morsica G
    J Biol Regul Homeost Agents; 2003; 17(2):198-204. PubMed ID: 14518724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus nonstructural 3 protein: recombinant NS3 protein of the Thai isolates as an antigen in a diagnostic assay.
    Kanistanon D; Wongprompitak P; Dharakul T; Songsivilai S
    Asian Pac J Allergy Immunol; 2002 Sep; 20(3):161-6. PubMed ID: 12587839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and purification of hepatitis C virus protease from clinical samples.
    van der Helm L
    Methods Mol Biol; 2013; 1030():119-27. PubMed ID: 23821264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic heterogeneity of the hepatitis C virus NS5A protein.
    Dou XG; Talekar G; Chang J; Dai X; Li L; Bonafonte MT; Holloway B; Fields HA; Khudyakov YE
    J Clin Microbiol; 2002 Jan; 40(1):61-7. PubMed ID: 11773093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a simple assay in vitro for hepatitis C virus NS3 serine protease based on recombinant substrate and single-chain protease.
    Du GX; Hou LH; Guan RB; Tong YG; Wang HT
    World J Gastroenterol; 2002 Dec; 8(6):1088-93. PubMed ID: 12439931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection and application of serotypical synthetic peptides derived from hepatitis C virus NS5A region.
    Dou XG; Zhang L; Li ZW; Feng GH; Chang J; Fildes H; Khudyakov Y
    Chin Med J (Engl); 2007 Jul; 120(13):1159-65. PubMed ID: 17637245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of robust in vitro serine protease assay based on recombinant Pakistani HCV NS3-4A protease.
    Fatima K; Tahir M; Qadri I
    Virus Res; 2011 Sep; 160(1-2):230-7. PubMed ID: 21756947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenicities of Group I and II hepatitis C virus polypeptides--molecular basis of diagnosis.
    Tsukiyama-Kohara K; Yamaguchi K; Maki N; Ohta Y; Miki K; Mizokami M; Ohba K; Tanaka S; Hattori N; Nomoto A
    Virology; 1993 Feb; 192(2):430-7. PubMed ID: 7678473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an efficient
    Naguib MM; Mohamed MR; M Ali MA; Karim AM
    Indian J Pathol Microbiol; 2019; 62(3):391-398. PubMed ID: 31361226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.